Skip to main content

Table 2 Clinical characteristics of patients with systemic sclerosis

From: High-throughput quantitative histology in systemic sclerosis skin disease using computer vision

Clinical CharacteristicPrimary CohortSecondary Cohort
Mean ± Standard Deviation or as indicatedSSc patients (n = 6)SSc patients (n = 60)Healthy controls (n = 16)
Age54 ± 650 ± 1142 ± 12
Women (n, %)5 (83%)52 (87%)13 (81%)
Race, Caucasian (n, %)5 (83%)45 (75%)12 (75%)
SSc disease duration (months)*11 ± 338 ± 51 
dcSSc (n, %)6 (100%)42 (70%) 
mRSS (median, IQR)15 (8)15 (8) 
Serum autoantibodies (n, %)
 Anticentromere04 (7%) 
 Anti-RNA polymerase III3 (50%)15 (25%) 
 Anti-topoisomerase I (Scl-70)2 (33%)19 (31%) 
  1. *Months between date of onset of first non-Raynaud systemic sclerosis (SSc) symptom and date of skin biopsy. dcSSc Diffuse cutaneous SSc
\